Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
GlobalData on MSN
Stereotaxis secures FDA approval for ablation catheter
The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of ...
Stereotaxis was forced to do a human trial for its Magic catheter before it can get CE Mark. This is starting in a few weeks. Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter ...
(RTTNews) - Stereotaxis, Inc. (STXS), a global leader in surgical robotics for minimally invasive interventions, announced on Monday that it has received European CE Mark approval for its MAGiC ...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback